PD-L1 detection on circulating tumor-derived extracellular vesicles (T-EVs) from patients with lung cancer

BACKGROUND: Recent breakthroughs in therapies with immune checkpoint inhibitors (ICIs) have revolutionized the treatment of lung cancer. However, only 15–25% of patients respond to the ICIs therapy, and methods to identify those responsive patients are currently a hot research topic. PD-L1 expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Fei, Gu, Yanzi, Kang, Bin, Heskia, Fabienne, Pachot, Alexandre, Bonneville, Marc, Wei, Ping, Liang, Ji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264343/
https://www.ncbi.nlm.nih.gov/pubmed/34295653
http://dx.doi.org/10.21037/tlcr-20-1277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264343/
https://www.ncbi.nlm.nih.gov/pubmed/34295653
http://dx.doi.org/10.21037/tlcr-20-1277

Ejemplares similares